LONG-TERM DAILY OUTPATIENT HEPARIN THERAPY IN HYPERLIPEMIC AND NORMOLIPEMIC ATHEROSCLEROTIC STATES
- Elucidating atherosclerotic vulnerable plaque rupture by modeling cross substitution of ApoE mouse and human plaque components stiffnesses. Ohayon, Jacques; Mesnier, Nicolas; Broisat, Alexis; Toczek, Jakub; Riou, Laurent; Tracqui, Philippe // Biomechanics & Modeling in Mechanobiology;Jul2012, Vol. 11 Issue 6, p801
The structure of mouse atherosclerotic lesions may differ from that of humans, and mouse atherosclerotic plaques do not rupture except in some specific locations such as the brachiocephalic artery. Recently, our group was the first to observe that the amplitudes of in vivo stresses in ApoE mouse...
- THE EFFECT OF SUBLINGUAL HEPARIN ON LIPOPROTEIN DISTRIBUTION IN ATHEROSCLEROSIS. Biancani, G. // Angiology;Apr1961, Vol. 12 Issue 4, p119
Focuses on the capability of sublingual heparin in restoring the distribution of lipoprotein in the body in the treatment of atherosclerosis. Cause of atherosclerosis; Importance of the clearing factor of the heparin in its capacity in treating atherosclerosis; Developments in the heparin therapy.
- Accelerated atheroma and anti ï¿½2-glycoprotein I antibodies. Matsuura, E.; Koike, T. // Lupus;2000, Vol. 9 Issue 3, p210
Examines the possible involvement of auto-antibodies against anti-beta2- glycoprotein in accelerated atherosclerosis. Serological reactivity of antiphospholipid antibodies and anti-beta2-glycoprotein I antibodies; Biological nature and antigenicity of beta2-glycoprotein I; Oxidative...
- DISCUSSION. Sanchez, Luis A. // Vascular Surgery;Mar/Apr1997, Vol. 31 Issue 2, p161
Comments on a study by Phillip J. Bendick et al on the arterial adaptation to increased wall shear stress. Factor associated with the development of atherosclerotic plaques; Purpose of the technique used in non-atherogenic model.
- Pathology of AtheroThrombosIS (ATIS). // Drugs;2010 Supplement 1, Vol. 70, p3
No abstract available.
- Impact of renal function on coronary plaque composition. Miyagi, Motohiro; Ishii, Hideki; Murakami, Ryuichiro; Isobe, Satoshi; Hayashi, Mutsuharu; Amano, Tetsuya; Arai, Kosuke; Yoshikawa, Daiji; Ohashi, Taiki; Uetani, Tadayuki; Yasuda, Yoshinari; Matsuo, Seiichi; Matsubara, Tatsuaki; Murohara, Toyoaki // Nephrology Dialysis Transplantation;Jan2010, Vol. 25 Issue 1, p175
Background. Recent studies have demonstrated that patients with chronic kidney disease are at high risk of atherosclerosis. Recently it has been found that coronary plaque components can be evaluated by integrated backscatter intravascular ultrasound (IB-IVUS), and lipid-rich plaque is...
- Stability analysis of a model of atherogenesis: An energy estimate approach. Ibragimov, A. I.; McNeal, C. J.; Ritter, L. R.; Walton, J. R. // Computational & Mathematical Methods in Medicine;Jun2008, Vol. 9 Issue 2, p121
Atherosclerosis is a disease of the vasculature that is characterized by chronic inflammation and the accumulation of lipids and apoptotic cells in the walls of large arteries. This disease results in plaque growth in an infected artery typically leading to occlusion of the artery....
- Aortoiliac Occlusion Associated with the Lupus Anticoagulant. Setoguchi, Motoko; Fujishima, Yae; Abe, Isao; Kobayashi, Kazuo; Fujishima, Masatoshi // Angiology;Apr1997, Vol. 48 Issue 4, p359
Aortoiliac occlusion due to atherosclerosis is known to occur in elderly people. Two unique cases are documented here in which aortoiliac occlusion was observed in young men. These patients had no identifiable risk factors for developing atherosclerotic thrombosis except for the lupus...
- Fragmin. // Royal Society of Medicine: Medicines;2002, p257
The article presents information on fragmin. The drug is a proprietary, prescription-only preparation of the dalteparin sodium, which is a low molecular weight version of heparin. It can be used for long-duration prevention of venous thrombo-embolism, particularly in orthopaedic use, It is...